Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.88% | 23.96% | 16.21% | 9.36% | 3.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.88% | 23.96% | 16.21% | 9.36% | 3.96% |
| Cost of Revenue | 25.45% | 19.21% | 11.72% | 6.32% | 2.26% |
| Gross Profit | 36.03% | 28.47% | 20.56% | 12.37% | 5.63% |
| SG&A Expenses | 19.44% | 19.78% | 13.09% | 5.70% | 4.19% |
| Depreciation & Amortization | 68.22% | 64.50% | 40.34% | 19.39% | -3.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.81% | 21.44% | 13.59% | 6.66% | 2.77% |
| Operating Income | 104.57% | 53.73% | 51.44% | 54.01% | 20.81% |
| Income Before Tax | 67.02% | -2.92% | 12.65% | 41.75% | 25.57% |
| Income Tax Expenses | 3.57% | 8.04% | 15.28% | 17.25% | 38.04% |
| Earnings from Continuing Operations | 127.62% | -10.74% | 10.57% | 84.51% | 15.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 127.62% | -10.74% | 10.57% | 84.51% | 15.66% |
| EBIT | 104.57% | 53.73% | 51.44% | 54.01% | 20.81% |
| EBITDA | 90.87% | 63.35% | 53.51% | 44.00% | 16.96% |
| EPS Basic | 149.30% | -34.12% | -11.88% | 63.89% | 1.43% |
| Normalized Basic EPS | 65.10% | -19.13% | -1.61% | 33.33% | 18.52% |
| EPS Diluted | 200.00% | -54.63% | -38.31% | 30.30% | -17.91% |
| Normalized Diluted EPS | 62.50% | -21.30% | -2.15% | 32.58% | 18.52% |
| Average Basic Shares Outstanding | 12.01% | 2.46% | -0.14% | -2.74% | -2.74% |
| Average Diluted Shares Outstanding | 16.63% | 6.94% | 3.19% | 0.59% | -2.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |